A 46-year-old woman with type 1 myotonic dystrophy (DM1) presented to the emergency department with dyspnea and palpitations.

Scientists present current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec.

Families began receiving calls from doctors last week to arrange treatments for new Givinostat drug after a campaign by the ...

To help neurologists, clinicians and families understand the current evidence for a new gene therapy for Duchenne muscular ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, shared the following ...

Canadians are walking, running, and rolling in support of the 30th annual Walk to Defeat Duchenne, the country's only ...

To help neurologists, clinicians and families understand the current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec, the American Academy of ...

I had the pleasure of attending a Netflix event around the WoW documentary The Remarkable Life of Ibelin last year—one that was attended by folks from Muscular Dystrophy UK, a charity that helps fund ...

The "Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2025" report provides a comprehensive overview of the global clinical trials landscape for Duchenne Muscular Dystrophy. It includes ...

Fresno firefighters are taking action and asking for your help. Monday morning, firefighters will be in north Fresno asking ...

Get Instant Summarized Text (Gist) Chronic muscle inflammation in Duchenne muscular dystrophy (DMD) is driven by both infiltrating and resident macrophages, the latter stimulated by CSF-1 produced ...